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An aptasensor for the detection 
of Mycobacterium tuberculosis 
secreted immunogenic protein 
MPT64 in clinical samples towards 
tuberculosis detection
Marzhan Sypabekova1,2, Kanat Dukenbayev  3, Anna tsepke4, Akmaral Akisheva4, 
Nurlan Oralbayev4 & Damira Kanayeva5*
This work presents experimental results on detection of Mycobacterium tuberculosis secreted protein 
MPT64 using an interdigitated electrode (IDE) which acts as a platform for capturing an immunogenic 
protein and an electrochemical impedance spectroscopy (EIS) as a detection technique. The assay 
involves a special receptor, single stranded DNA (ssDNA) aptamer, which specifically recognizes MPT64 
protein. The ssDNA immobilization on IDE was based on a co-adsorbent immobilization at an optimized 
ratio of a 1/100 HS-(CH6)6-OP(O)2O-(CH2CH2O)6-5′-TTTTT-aptamer-3′/6-mercaptohexanol. The optimal 
sample incubation time required for a signal generation on an aptamer modified IDE was found to be 
at a range of 15–20 min. Atomic Force Microscopy (AFM) results confirmed a possible formation of an 
aptamer - MPT64 complex with a 20 nm roughness on the IDE surface vs. 4.5 nm roughness for the IDE 
modified with the aptamer only. A limit of detection for the EIS aptasensor based on an IDE for the 
detection of MPT64 in measurement buffer was 4.1 fM. The developed EIS aptasensor was evaluated on 
both serum and sputum clinical samples from the same TB (−) and TB (+) patients having a specificity 
and sensitivity for the sputum sample analysis 100% and 76.47%, respectively, and for the serum 
sample analysis 100% and 88.24%, respectively. The developed aptasensor presents a sensitive method 
for the TB diagnosis with the fast detection time.
Tuberculosis (TB) is the leading cause of death from a single infectious agent accounting for over 1.33 million 
deaths in 2017 of the total 10 million infected people1. The distribution of TB epidemics varies by country with 
the most prevalence being in Africa (72%), India (27%), China (9%), Indonesia (8%), and Philippines (6%)2. The 
complication of TB control is also affected by the continuing emergence of drug resistant strains in countries such 
as India (21%), China (13%), and Russian Federation (10%) and countries of the former Soviet Union (8.5%)1. 
Moreover the 23% of the world’s population are estimated to have a latent TB infection, being at higher risk of 
developing TB during their life time1,2.
Technological breakthrough and intensified research are the priority targets of the end TB Strategy 2030 by 
World Health Organization (WHO) in fields of rapid diagnostics for the use at the point of care1. Current TB 
diagnostics tests include a DNA amplification test, sputum smear microscopy, and culture-based methods3. The 
DNA amplification test recommended by WHO is the Xpert MTB/RIF assay (Cepheid, USA) which targets the 
diagnosis of TB that can provide results within two hours1. The test is highly sensitive, however, it can identify the 
genetic information of both viable and dead M. tuberculosis with high precision and accuracy4. Moreover, since 
the test is not so cheap, in resource-limited countries, where TB is at the highest rate, such tests are performed 
only for specific and special cases. Sputum smear microscopy is a common diagnostic test, which involves an 
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examination of the sputum sample under the microscope for the presence of M. tuberculosis. The technique is 
straightforward, however, less sensitive with the possibility of providing false-negative results. Culture-based 
methods involve the growth of M. tuberculosis in special conditions in BSL-3 laboratories for at least 2–8 weeks 
for obtaining the results extending the diagnosis time.
The level of expression of the MPT64 protein is high in individuals with an active TB. The main function of the 
protein is to promote survival and persistence in the host cell. It deactivates the expression of apoptotic cytokines, 
hence, plays a major role in survival and virulence of the mycobacteria5. MPT64 is expressed and secreted by the 
actively dividing M. tuberculosis along with other 33 predominantly secreted proteins by MTBC6–8. Such secreted 
proteins, also called antigens, are recognized by immune cells and initiate the first host immune response. The 
MPT64 protein can be found both in sputum and serum exosomes of a TB infected patient9,10.
This work presents an alternative way of diagnosing an active TB in sputum and serum clinical samples. The 
test involves a special receptor, single stranded DNA (ssDNA) aptamer, immobilized on an interdigitated microe-
lectrode (IDE), which acts as a platform for capturing an immunogenic protein MPT64. The ssDNA aptamer used 
in the assay had a sequence of 40 nucleotides and was selected by Systematic Evolution of Ligand by Exponential 
Enrichment (SELEX) method against MPT6411,12. MPT64 ssDNA aptamer had a modified structure in the form 
of HS-(CH2)6-OP(O)2O-(CH2CH2O)6-5′-TTTTT-aptamer-3′. The surface chemistry was based on a simple and 
straightforward procedure of co-immobilization of an aptamer and 6-mercaptohexanol (MCH). The overall 
detection time of the assay was reduced from several hours down to 15 min, and the sensitivity was increased up 
to a fM range as compared to previously published results13. The surface chemistry used in the assay for improved 
MPT64 detection was based on a co-adsorbent immobilization at an optimized ratio of 1/100 ssDNA aptamer/
MCH13. The surface chemistry used in this study was based on simultaneous immobilization of both aptamer and 
co-adsorbent in the form of MCH, and, hence, the procedure is simple with minimal cost.
Results
Aptasensor optimization studies. The overall set-up of the aptasensor is presented in Fig. 1. It consists 
of a portable potentiostat that is connected to the modified IDE with an aptamer/MCH complex at a ratio of 
1/100 and a portable computer. An optimization study of the target protein incubation time was performed, 
where a 1fM MPT64 was incubated on the modified IDE at time points of 5, 10, 15, and 20 min (Fig. 2a). The 
IDE surface was modified by the aptamer/MCH complex at a ratio of 1/100, and the EIS signal was measured in 
the SELEX buffer (50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 7.5). After incubation with MPT64 protein, 
IDE was rinsed with the measurement buffer, and EIS was recorded in the measurement buffer with 2 mM ferro/
ferricyanide [Fe(CN)6]3−/4− redox couple. The EIS signal was fitted with the equivalent Randles circuit (Fig. 3d) 
and charge transfer resistance Rct with an error value below 2% was used to report the results. The change in 
charge transfer resistance (Rct) was calculated by subtracting the Rct value of an electrode without protein from 
the electrode incubated with protein at respective incubation times. The results show that at 5, 10, 15, and 20 min 
protein incubation time, the average change in Rct value was 2.85, 2.83, 8.85, and 8.98%, respectively (Fig. 2a). The 
statistically significant difference between the 5–10 min incubation time and 15–20 min incubation based on one-
way analysis of variance presented P value as 0.0004 which was below 0.05 indicating the significant statistical 
difference between the two incubation timing sets.
Specificity test. The aptasensor was tested for its specificity against other non-target proteins such as 
ESAT-6 and CFP-10. The aptasensor, measured with redox markers in a solution, showed a Rct signal change 
that increased by 65.98% at 1 nM and 24.48% at 0.05 pM when it was incubated with MPT64 protein, whereas, it 
remained less than 18% at 1 nM and 5% at 0.05 pM for the control proteins ESAT-6 and CFP-10 (Fig. 2b). Change 
in Rct of the IDE was measured after 15 min protein incubation followed by rinsing and measurement in SELEX 
buffer (50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 7.5) containing 2 mM ferro/ferricyanide [Fe(CN)6]3−/4− 
redox couple. The statistically significant difference between the binding to MPT64, ESAT-6, and CFP-10 based 
on one way analysis of variance showed that at a 0.05 pM protein concentration the P value was 0.09 and for a 
1 nM protein concentration the P value was 0.005 which indicates that the statistical difference for the later con-
centration was significantly different.
Concentration-dependent analysis. The charge transfer resistance Rct of the clean bare IDE was 2.714% 
(Fig. 3a and Table 1). The electrode surface was modified by immobilizing an aptamer/co-adsorbent complex as 
described in aptamer/MCH immobilization on the IDE Section. After incubation with the aptamer/MCH, Rct 
increased to 4.164% as the DNA aptamer probe is negatively charged and, therefore, inhibited electrons from the 
mediator reaching the electrode14. Incubation with the 25 nM MPT64 caused a further increase in Rct change up 
to 4.734%.
A concentration-dependent curve for different MPT64 concentrations relative to blank measurements from 
the EIS signal measured in SELEX buffer (50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 7.5) is presented in 
Fig. 3b. A concentration-dependent analysis was performed for MPT64 concentrations ranging from 0.1 fM to 
1 nM and showed a corresponding increase in Rct. Figure 3d shows the Randles equivalent circuit model selected 
to fit the experimental data, in which Rs is the solution resistance connected in series with the double layer capac-
itance CDL and in parallel with the charge transfer resistance Rct of the surface and Warburg element W to model 
diffusion. A concentration-dependent response was obtained with a gradual increase in Rct signal up to 1 nM 
MPT64 demonstrating a good response down to concentration of 1 fM with the limit of detection (LoD) of 4.1 
fM for MPT64 detection. The lowest concentration that was tested for MPT64 was 0.1 fM. The LoD was calcu-
lated using the formula LoD = mean blank + 1.645(SDblank) + 1.645(SDlow concentration sample), where SD is the standard 
deviation15,16. The signal for SELEX buffer with the target MPT64 protein alone remained unchanged throughout 
the experiment (Fig. 3b, red round dots). The surface of the sensor did not saturate at 1 nM of MPT64. Figure 3c 
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presents an experimental Nyquist plot for binding of MPT64 at concentrations ranging from 0.1 fM to 5 nM. A 
fitting circuit was used in this study to quantify the target analyte.
Surface characterization studies with an AFM imaging. Bare IDE was cleaned as indicated in the 
Section Electrode cleaning. AFM imaging showed that the surface roughness of a clean IDE was around at 2.6 nm 
(Fig. 4a,b). The IDE surface was further functionalized with DNA aptamer/MCH complexes that had the average 
roughness of the IDE increased up to 4–4.5 nm as compared to the bare IDE indicating a successful immobili-
zation of aptamers (Fig. 4c,d). The aptamer size used in this study was relatively small (40 nucleotides), and its 
single-stranded nature made them fold into favourable shape and, hence, appeared as a small globular structure 
under the AFM. The IDE was then incubated with a 1 nM MPT64 for 15–20 min followed by rinsing to remove 
any unbound material from the surface and consequent drying under the gentle stream of N2. It can be seen from 
Fig. 4e,f that there was MPT64 protein captured on the IDE surface that potentially formed protein-protein com-
plexes as the surface roughness of the IDE increased up to 20 nm, and a topography of the IDE surface showed 
large globular structures.
Clinical sample analysis. Clinical samples were tested to further evaluate performance of the developed 
aptasensor. Overall, 17 TB (+) and 4 TB (−) clinical samples were evaluated. Both serum and sputum sam-
ples were analyzed from the same patient to observe the performance of the MPT64 aptasensor on a type of 
sample. Hospital personnel collected the sputum and serum samples from patients in special containers at 
Figure 1. An experimental set-up (a) real, and (b) schematic comprising a PC and electrodes (IDE, CE, 
RE) that were connected to the portable potentiostat. The active area of the IDE indicated by a red rectangle 
composed of two interdigitated electrodes with two connection tracks, all made of gold, on a glass substrate 
with bands/gaps at 5 µm with dimensions L 22.8 × W 7.6 × H 0.7 mm. The part of the active area was magnified 
under the microscope. The gold coated surface of the IDE fingers was modified with the aptamer/MCH 
complex at a ratio of 1/100. The detection was based on the binding event of the target MPT64 onto the aptamer 
modified electrode surface.
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Figure 2. (a) An optimization study of the incubation time (5, 10, 15, and 20 min) required for a 1 fM MPT64 
detection with the use of the electrochemical aptasensor and aptamer/MCH modified IDE. (b) A specificity 
study of the electrochemical aptasensor for the target MPT64 detection along with CFP-10 and ESAT-6 at 
different concentrations based on the DNA aptamer/MCH surface chemistry at an optimized ratio of 1/100.
Figure 3. (a) The representative Nyquist plot (−Z″ vs. Z′) of bare IDE, after an aptamer/MCH immobilization 
step and a 25 nM MPT64 detection in the frequency range from 0.1 Hz to 50 MHz with a 10 mV a.c. The 
measurements were recorded in SELEX buffer containing 2 mM ferro/ferricyanide [Fe(CN)6]3−/4− redox couple. 
(b) A concentration-dependent curve for different MPT64 concentrations using aptamer/MCH at a ratio 
of 1/100 relative to blank measurements from the EIS signal measured in SELEX buffer. (c) Experimentally 
obtained Nyquist plot for binding to MPT64 at concentrations from 0.1 fM to 5 nM. (d) Randles equivalent 
circuit, where Rs is the solution resistance, Rct is the charge transfer resistance, CDL is the double layer 
capacitance, and W is the Warburg element.
Step ∆Rct (%)
Bare IDE 2.714
Aptamer/MCH 4.164
After 25 nM MPT64 binding 4.734
Table 1. The Rct change of the bare IDE, aptamer/MCH modified IDE and after 25 nM MPT64 binding.
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anti-Tuberculosis dispensary (Nur-Sultan, Kazakhstan). All samples were confirmed for the presence of M. tuber-
culosis in TB infected patient samples using an AFB staining microscopy (Fig. 5). Samples from four TB (−) 
individuals were used as a control.
As it can be seen from Fig. 6a,c, the general trend shows that there was a higher change in Rct signal when the 
electrode was incubated with TB (+) patient samples. The Rct for TB (+) serum sample analysis increased from 
25.44% up to 166.58%, it remained less than 34.47% for TB (−) samples (Fig. 6a). The Rct for TB (+) sputum sam-
ple analysis varied from −13.14% to 116.04 and for TB (−) samples varied from −0.92% to −22.53% (Fig. 6c). 
Figure 4. AFM topographical micrographs in air of G-IDEAU 05 type gold plated IDE surfaces. (a,b) 2D and 
3D micrographs of a bare IDE with the surface roughness of around 2.6 nm. (c,d) 2D and 3D micrographs of the 
IDE surface functionalized with DNA aptamer/MCH complexes with an average roughness of the IDE surface 
of 4–4.5 nm high. (e,f) 2D and 3D micrographs of the aptamer functionalized IDE surface that captured a 1 nM 
MPT64 with the IDE surface roughness of up to 20 nm high.
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The dotted line in Fig. 6c was placed to separate the positive and negative Rct values. The specificity and sensitivity 
of the sputum sample analysis were calculated as 100% (95 CI: 50.1–93.19%) and 76.47% (95% CI: 39.76–100.0%), 
respectively, using Youden’s index. The area under the curve (AUC) for sputum samples was 91.18% (95% CI: 
Figure 5. A representative micrograph of M. tuberculosis bacilli using an AFB staining technique from a 
sputum sample of a TB infected patient. Arrows indicate stained rod-shaped bacilli corresponding to the 
presumptive M. tuberculosis.
Figure 6. Evaluation of the aptasensor using clinical (a) serum and (c) sputum samples from infected TB (+) 
(active form) and TB (−) individuals and respective ROC curves (b,d).
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73.51–100%) from the ROC curve (Fig. 6d). Specificity and sensitivity of the serum sample analysis were 100% 
(95% CI: 39.76–100.0%) and 88.24% (95% CI: 63.56–98.54%), respectively. The AUC for serum sample was 94% 
(95% CI: 80.6–100%) (Fig. 6b).
Discussion
In this paper, we further evaluated the performance of the aptasensor for the detection of MPT64 in clinical 
samples. The immobilization of the aptamers based on the optimized surface chemistry13 was done on the surface 
of the IDE, and the EIS signal was recorded using the portable potentiostat. EIS is the technique used in imped-
imetric electrochemical biosensors. As compared to other biosensors, the impedimetric technique provides low 
cost, low power, scalable, and highly sensitive and label-free measurement with minimal hardware demand17. The 
EIS Faradaic mode was used within the scope of this work. It is based on transportation of redox species (ferro/
ferricyanide) between the electrode and electrolyte solution and, hence, measures the resistance for electron 
transfer. The signal in this way can be recorded within a small change of analyte binding event based not only on 
molecular interaction level but also on electron/charge transfer levels13 hence provides sensitive detection down 
to attomolar range18,19.
IDE is a special platform with separated metal plates that have a number of digits overlapping with one 
another. Figure 1b represents a micrograph of the IDE with an active area to which the aptamer was immo-
bilized. Prior surface modification, each IDE electrode was cleaned as described in the Electrode Cleaning 
Section. Cleaning of the IDE surface was an essential step in the aptasensor development as it removed physically 
adsorbed random molecules and any dust from the IDE surface. The application of an electric signal onto the IDE 
created an electric field between the digits. When a specific molecule (e.g. protein, DNA, cell) immobilized on 
the digits, the electric field was altered or disrupted resulting in the change of electric field. The geometry of the 
IDE (digit width and spacing) played an important role in the aptasensor sensitivity. The sensitivity of the sensor 
increases with a decreasing distance between the digits20,21. Therefore, analytes with different sizes (bacteria22, 
virus23, protein24, DNA25) could be detected using the IDE with different interdigit spacing (100–250 µm, 15 µm, 
5–10 µm, 150 nm, respectively). In general, IDEs have a relatively small dimension, which makes them suitable 
to integrate with a miniaturized device as well as to analyze a small sample volume in the absence of interference 
with selectivity and response time. In this study, for the detection of MPT64 protein, we used the IDE with the 
interdigit spacing of 5 µm for the aptamer immobilization. It should be noted that Fig. 3a, represents the imped-
ance spectra for modification steps for one particular electrode. The general trend in decrease/increase of Rct 
change before and after cleaning, after aptamer/MCH complex immobilization and protein incubation for other 
electrodes, was similar.
The LoD of the sensor was increased up to 4 fM in the measurement buffer, showing the improved sensitivity 
of using the IDE for MPT64 detection as compared to the LoD 81 pM using a plane gold electrode as an immo-
bilization platform13. An increase in charge transfer resistance (Rct) was observed with an increasing MPT64 
concentrations from 0.1 fM to 1 nM (Fig. 3b). A 40 nucleotide long DNA aptamer with a long linker in the form of 
HS-(CH2)6-OP(O)2O-(CH2CH2O)6-TTTTT-aptamer (Fig. 1) was used in the study. The function of the thymine 
residues was to provide spacing for improved interaction with the protein as well as eliminate the direct adsorp-
tion of the aptamer onto the electrode surface. The long linker used in this study was based on a hydrophilic 
ethylene glycol (CH2CH2O)6 group which enabled the aptamer sequence to protrude from the modified electrode 
surface. Ethylene glycol was also used to eliminate any steric hindrance associated with the binding process as 
well as to reduce a non-specific interaction26,27.
The AFM micrographs revealed the formation of a complex between the immobilized aptamer and the MPT64 
protein, where the surface roughness of the IDE surface was increased from 4.5 nm up to 20 nm after protein 
incubation (Fig. 4a–f). The shape of the complexes as well as the variations in height from 5–20 nm is indicative 
of non-uniform IDE surface coverage after protein incubation. The relationship between the surface roughness 
measured by AFM (2.6 nm; 4–4.5 nm; 20 nm, respectively) and a change in Rct signal detected by EIS (2.714%; 
4.164%; 7.734%) for a bare electrode, an aptamer/MCH functionalized electrode, and an electrode capturing 
the target MPT64 had a correlation in values except for the value in the aptamer/MCH functionalized electrode. 
Although two methods were based on different detection methods, one was measured in a solution (EIS) and the 
other was measured in air (AFM) there more experiments could be done since AFM cannot fully provide adsorp-
tion properties of the complex formation.
The incubation time optimization studies showed that time required for protein binding at 5 min and 10 min 
had on average relatively large error bars in comparison to 15 min and 20 min incubation time (Fig. 2a). This 
inconsistency could be due to the instability of the target protein on the surface as well as indicative of large signal 
variability from one electrode to another. The change in Rct value was increased three times higher at 15 min and 
20 min (Fig. 2a) as compared to 5–10 min incubation time. The increase in Rct signal after 15 min incubation time 
could correspond to protein stabilization and specific recognition by the aptamers immobilized on the surface of 
the IDE. It was concluded that 15–20 min sample incubation time on IDE modified surface is optimal for record-
ing the EIS signal and, hence, reducing the overall detection time.
The aptasensor showed specificity towards MPT64 as compared to other M. tuberculosis secreted immuno-
genic proteins such as ESAT-6 and CFP-10. Perilous study with the same aptamer sequence showed that aptamer 
had very good specificity towards MPT64 protein as compared to other proteins such as PSA, CEA, and HSA13. 
HSA, CEA, and PSA are biomarkers that present in human serum and associated with other diseases such as can-
cer but not related to TB28,29. In the current study, we tested the developed aptasensor for its specificity towards 
M. tuberculosis secreted proteins, such as CFP-10 and ESAT-6 along with MPT64 (Fig. 2b). CFP-10 (10 kDa) and 
ESAT-6 (6 kDa) are proteins involved in M. tuberculosis virulence. They are one of the most abundant antigens of 
M. tuberculosis grown in the culture30. CFP-10 and ESAT-6 are encoded by genes aligned in pairs in the M. tuber-
culosis genome. The product of the genes is then secreted by specialized transport system31,32. ESAT-6 and CFP-10 
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form a tight one to one complex31. One of the main characteristics of this complex is that C-terminus of CFP-
10 forms a long flexible arm, which plays an important role in a cell surface attachment specifically binding to 
macrophages and monocytes These proteins like MPT64 also stimulate the production of T-cells and are among 
candidate vaccines for TB33. As it can be seen from Fig. 2b the aptasensor is more specific towards the MPT64 
protein as compared to ESAT-6 and CFP-10. The inconsistency in large error bars for the ESAT-6 and CFP-10 
could be due to non-specific binding of the control proteins to the functionalized surface.
The current study also presents results on the potential application of the developed aptasensor using clinical 
samples. The conventional TB diagnostic technique Acid Fast Bacilli (AFB) staining microscopy uses the sputum 
sample for the identification of M. tuberculosis1. MPT64 protein is secreted by and expressed on the actively divid-
ing M. tuberculosis34, therefore in this assay, the sputum sample was used to test the aptasensor for the presence 
of MPT64. Later studies showed the presence of MPT64 protein also in serum samples10. Therefore, in addition 
to the sputum sample in this study, serum sample was also used to evaluate the aptasensor for the presence of 
MPT64. ROC curve analysis was used for the evaluation of the diagnostic performance of the aptasensor, or the 
accuracy of the test to discriminate diseased cases from normal cases29. The ROC curve was plotted as the sen-
sitivity of a function of the false positive rate for a specific cut-off point. The closer the ROC curve to the upper 
left corner the higher the accuracy of test29. The Youden index J, in this work, was defined as J = max (sensitiv-
ity + specificity − 1) and corresponded to the maximum vertical distance between the ROC curve and the diag-
onal line35. Equal weight was given to sensitivity and specificity while selecting optimal Youden index criterion. 
Sensitivity in this test was considered as a probability that a test result would have been positive when the disease 
was present (true positive), and it was expressed in a percentage. Specificity was a probability that a test result 
would have been negative when the disease was not present (true negative). The results clearly showed the more 
Rct signal increase in TB positive samples with specificity and sensitivity for the sputum sample analysis being at 
100% and 76.47% and for the serum sample being at 100% and 88.24%, respectively. The results clearly show that 
there are still further improvements needs to be done to elevate the sensitivity of the assay. The sensitivity of the 
assay is considered reliable, which is above 94–65%. The composition of the clinical sample is very complex, and 
therefore, a non-specific binding of un-related bio-molecules on to the surface is an issue that every aptasensor 
may face. For instance, the non-specific binding of the HSA protein onto the MCH modified surface accounted 
in the increase of Rct signal by 4–6%13. It shows that, indeed, the signal from EIS could not be only due to the spe-
cific binding between aptamer and protein in interest but it could also account for the non-specific binding of an 
un-related biomolecules onto the electrode surface. In this instance, the signal to noise ratio needs to be carefully 
calibrated and set as well tuned surface chemistry to avoid a non-specific adsorption on the electrode surface. The 
preliminary results of this study showed that the aptasensor is capable of distinguishing TB (+) from TB (−) sam-
ples. However, we should mention that the threshold needs to be set to clearly identify the presence of MPT64.
Nevertheless, presented results showed that the IDE based aptasensor for the detection of M. tuberculosis 
secreted protein MPT64 works quite well for the analysis of both type of clinical samples, sputum and serum, with 
an emphasis more towards the serum sample analysis. One advantage of the clinical TB serum sample analysis 
with the use of the developed aptasensor is a safer way of handling of the serum sample during diagnosis and 
sample utilization after the measurement that would not require availability of high level biosafety laboratory 
facilities as it is required for the TB sputum sample diagnosis. The developed aptasensor can be further evaluated 
using an increased number of clinical samples for the better and concrete prognosis of the test. In addition, the 
signal enhancement could be obtained by using a secondary aptamer conjugated with nanoparticles for better 
confirmation of the results between TB (+) and TB (−) samples.
Materials and Methods
Reagents. Thiolated MPT64 aptamer in the form of HS-(CH6)6-OP(O)2O-(CH2CH2O)6-5′-TTTTT-aptamer-3′ 
were synthesized by Eurogentec (Belgium)11–13. Magnesium chloride (MgCl2, ≥99%), sodium chloride (NaCl, 
≥99.5%), sulfuric acid (H2SO4, 96%), potassium hexacyanoferrate (III), potassium hexacyanoferrate (II) trihy-
drate, and 6-mercapto-1-hexanol (MCH) used in the sample preparation were of analytical grade and purchased 
from Sigma-Aldrich, UK. Tris base (≥99.0%), isopropanol (propan-2-ol, HPLC grade) were purchased from Fisher 
Scientific. Absolute ethanol was purchased from Aidabul Distillery (Kazakhstan). Target immunogenic protein 
MPT64 (46 kDa) (Rv1980c) (Gene ID: 581375; Accession#: CAA53143) of Mtb H37Rv strain with a concentration 
of 1 mg/ml was obtained from EnoGene Biotech Co Ltd (Nanjing, China). His and Trx tagged MPT64 protein was 
purified from recombinant Escherichia coli strain by an affinity chromatography with a >90% purity. According to 
the manufacturer, the protein was suitable for the use in multiple immunoassay formats, including ELISA, Western 
Blot, and rapid tests. Non-target ESAT-6 (p463-1) and CFP-10 proteins were purchased from Sunny lab (USA). All 
aqueous solutions were prepared using 18.2 MΩcm ultra-pure water with a Pyrogard filter (Millipore, UK).
Instrument. The data acquisition was performed with the Palmsens3 impedance analyzer (PalmSens BV, the 
Netherlands) with the PSTrace5 software. A three-electrode cell with an Ag/AgCl electrode (Ametek-AMT, Oak 
Ridge, TN, USA) and a platinum (Pt) counter electrode (Ametek-AMT, Oak Ridge, TN, USA) was used for all 
measurements. The tip of the Ag wire was coated with Ag/AgCl ink (ALS, Japan) and dried overnight at room 
temperature. The EIS was measured in a buffer containing 2 mM ferro/ferricyanide [Fe(CN)6]3−/4− redox couple 
(potassium hexacyanoferrate II/III). The frequency range used for the measurement was in the range of 0.1 Hz to 
50 MHz with 56 frequencies and with a 10 mV a.c. voltage superimposed on a bias d.c. voltage. All measurements 
were performed at room temperature inside a custom-made Faraday cage and corresponding signal was recorded 
in a Nyquist plot. The impedance change was calculated as the difference between the impedance measured before 
and after the protein was captured onto the IDE.
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Electrodes. An IDE (DRP-G-IDEAU5, Dropsens, Spain) was composed of two interdigitated electrodes with 
two connection tracks, all made of gold, on a glass substrate with bands/gaps at 5 µm with dimensions L 22.8 × W 
7.6 × H 0.7 mm (Fig. 1b). Electrode consisted of 250 × 2 digits with digit length 6,760 µm. A cable connector 
(CACIDE, Dropsens, Spain) was used as an interface between an IDE and the potentiostat.
IDE surface cleaning. Cleaning of an IDE was performed by sonicating in a solution containing propanol-2, 
and ethanol for 5 min followed by thorough rinsing and sonicating the IDE for 10 min in water. The IDE was then 
dried under the gentle stream of N2 until fully dry. Microscopy was used to observe any irregularities on the IDE 
surface. Electrodes with smooth geometry were used for further analysis. To characterize the effect of the clean-
ing procedure on the IDE, EIS was conducted using the Palmsens3 impedance analyzer before and after cleaning 
steps in a solution containing 2 mM of ferri/ferrocyanide ([Fe(CN)6]3−/4−) in the measurement buffer (SELEX 
buffer: 50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 7.5).
Aptamer/MCH immobilization on the IDE. A schematic overview of the IDE surface modification with 
an aptamer/MCH complex is presented in Fig. 1b. For the development of the MPT64 aptasensor, 50 µl mixture of 
a 100 µM of thiolated DNA aptamer and 100 µM of co-adsorbent at a ratio of 1/100 was dropped on a pre-cleaned 
IDE and was incubated for 16 h at 4 °C in a humid chamber. MCH was initially diluted in absolute ethanol at 
100 mM to make a stock solution and was stored at −20 °C until further use. Further dilutions were prepared 
prior to incubation in the measurement buffer (SELEX buffer: 50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 
7.5). After incubation with the aptamer/MCH complex on the IDE, the electrode was rinsed with the measure-
ment buffer to remove any unbound ssDNA aptamers. A 50 µl of 1 mM of MCH was applied onto the surface of 
the IDE for another 1 h at room temperature to ensure complete thiol coverage on the gold surface and to displace 
a non-specific interaction between the DNA and gold36,37. After rinsing the IDE with the measurement buffer, it 
was then placed into the measurement buffer with 2 mM ferro/ferricyanide [Fe(CN)6]3−/4− redox couple for at 
least 1 h for stabilization purposes.
Protein detection. The aptamer modified IDE was incubated in a solution containing target MPT64. A 
wide range of MPT64 concentrations diluted in the measurement buffer from 0.1 fM up to 1 nM were tested in 
this study. After incubation with MPT64 protein the electrode was rinsed with the buffer to remove any of the 
remaining unbound residues from the electrode surface. The electrode was then placed in a measurement buffer 
and signal was recorded. For the specificity studies the electrodes were incubated with the proteins ESAT-6 and 
CFP-10 for 15 min followed by rinsing and measurement in a buffer with 2 mM ferro/ferricyanide [Fe(CN)6]3−/4− 
redox couple. A schematic overview of the aptasensor for the detection of MPT64 on the aptamer/MCH modified 
IDE surface is presented in Fig. 1b. All measurements were carried out at room temperature, in triplicates, and the 
mean value of replicates, standard deviations, and standard errors from the mean was used to report the results.
Atomic force microscopy imaging. Atomic force microscopy (AFM) was conducted to further con-
firm the binding of the target MPT64 protein onto the DNA aptamer immobilized microelectrode surface. The 
share-force topographical measurements of the cleaned IDE (described in Section Electrode cleaning), aptamer 
modified IDE (described in Section Aptamer/MCH immobilization on the IDE), and IDE after MPT64 incu-
bation (described in Section MPT64 detection) were scanned using an AFM system, AFM SmartSPM 1000 
(AIST-NT, Russia). Prior to the AFM scanning, the IDE electrode was rinsed with dH2O and gently dried under 
the stream of N2. All images were produced using AC-Mode (non-contact or tapping mode) of operation. 
Corresponding AFM images were performed in air at ambient temperature. Scanning size of all images is in XY 
directions was 1,000 nm to 1,000 nm. The height Z directions were adjusted automatically during scanning for the 
whole period of scanning. Measurements scanning rate was set at 0.2 Hz with pixel resolution at 1,024 × 1,024. To 
visualize high-resolution images, Super Sharp type NSG30_SS cantilevers (Tips Nano) with tip radius curvature 
up to 5 nm and force constant value of 22–100 N/m were used. The resonance frequency of a cantilever was in a 
range of 200–440 kHz.
Clinical sample analysis. Clinical samples were tested to further evaluate performance of the developed 
aptasensor on the detection of the target MPT64 protein. The aptasensor was tested on clinical samples obtained 
from TB patients based on serum and sputum samples. Analysis of samples was carried in a BSL-3 laboratory at 
the anti-tuberculosis dispensary, Nur-Sultan, Kazakhstan. The study was subject of exemptions from the ethical 
review of the Central (National) Ethics Commission (Ministry of Healthcare, Kazakhstan) and the Nazarbayev 
University research ethics committee. Written informed consents were received from the patients, and all sam-
ples were anonymized and coded. All methods were performed in accordance with relevant guidelines and 
regulations based on the criteria of Kazakhstani TB diagnostics standards. Overall, twenty-one sputum sam-
ples were screened, seventeen from patients with confirmed presence of M. tuberculosis, TB (+), and four from 
non-tuberculous controls, TB (−). Blood samples from patients were collected and centrifuged at 3,500 rpm for 
10 min. The supernatant-serum was further used in the analysis. Sputum samples were collected in sterile con-
tainers from TB (+) and TB (−) patients. Collected sputum and serum samples were stored at 4 °C and further 
analyzed by the developed MPT64 aptasensor on the same day. Both sputum and serum samples were diluted in 
SELEX buffer (50 mM Tris-HCl; 25 mM NaCl; 5 mM MgCl2; pH 7.5) where aptamers were previously selected 
at a 1/10 ratio followed by thorough mixing. A 50 µl of each clinical sample was placed onto the IDE surface and 
allowed to be incubated for 20 min at room temperature. IDE was then rinsed with the SELEX buffer to remove 
any unbound biological material from the IDE surface that was then connected to a portable impedance analyzer 
(PalmSens BV, the Netherlands) via the cable connector (CACIDE, Dropsens, Spain) inside the custom-made 
Faraday cage.
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Acid fast bacilli (AFB) staining. AFB staining microscopy is a technique that examines the sputum sam-
ples using a microscope to determine the presence of M. tuberculosis. AFB staining in this study was used to vis-
ually confirm the presence of the M. tuberculosis within 17 TB (+) sputum samples. The AFB staining microscopy 
was performed in the BLS-3 laboratory at the anti-Tuberculosis dispensary following the standard microscopy 
procedure approved by WHO. A wooden applicator was used to transfer a very thin layer of a sputum from a 
cloudy, serous, yellowish region onto a clean microscope slide. The dimension of the layer that was deposited on 
a slide was 1–2 cm. Then, the slide was air dried for 15 min, which was then heat fixed under the flame 3–4 times 
without overheating the slide. Next, the slide was flooded with carbol fuchsin, which was then heated to dry and 
rinsed off under tap water. The slide was then flooded with a 1% solution of hydrochloric acid in isopropyl alcohol 
(or methanol) to remove the carbol fuchsin, thus, removing the stain from cells that were unprotected by a waxy 
lipid layer. Thereafter, cells were stained with methylene blue, and slides with presumptive Mycobacterium cells 
were visualized under a microscope (Zeiss Axio Observer, Zeiss Germany) with an immersion oil. The presence 
of rod-shaped bacilli on the stained microscope slide as shown in Fig. 5 was regarded as TB (+) sample.
Data analyses. The diagnostic value of the assay using aptamers was evaluated using Receiver Operating 
Characteristics (ROC) curve analysis (GraphPad Prism 6, Graphpad Software, Inc). Rct change values for the EIS 
assay were plotted and the area under the curves (AUC) and 99% confidence intervals (95% CIs) were calculated. 
The optimal cut-points were determined based on the maximum value of Youden’s index (YI = specificity + sen-
sitivity − 1). All measurements were carried out in triplicates, and the mean value of replicates, standard devia-
tions, and standard errors from the mean were used to report the results. The statistically significant difference 
between the binding to MPT64, ESAT-6, and CFP-10, and the difference between the incubation times 5–10 min 
and 15–20 min was done using one-way analysis of variance analysis.
Conclusion
This work presented results on the development of the aptasensor for the detection of M. tuberculosis secreted 
protein MPT64. The bio receptor – aptamer was previously selected against to MPT64 with disassociation con-
stant KD   = 8.92 nM11. The aptamers were immobilized on an IDE electrodes and EIS was used as a detection 
method. The sensitivity of the sensor in buffer was improved down to LoD 4.1 fM compared to previously pub-
lished data. The incubation time was optimized and set as 15–20 min. The developed aptasensor was tested on 
clinical samples from TB(+) and TB(−) patients with specificity and sensitivity for the sputum sample analysis 
100% and 76.47%, respectively, and for the serum sample analysis 100% and 88.24%, respectively. The proposed 
aptasensor could be studied and improved further such as analyzing the IDE surface composition after the clinical 
sample incubation with a spectroscopic technique as well as establishing a threshold for the noise to signal ratio. 
Overall, this study demonstrated that aptasensor platforms could be successfully employed in clinical sample 
analyses, aiming to exploit the advantages of this method for biomolecule detection.
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